Artwork

Content provided by Ketamine Wellness Centers. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ketamine Wellness Centers or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

A Closer Look at Spravato (Esketamine): How will it be administered?

9:44
 
Share
 

Manage episode 229049010 series 1756689
Content provided by Ketamine Wellness Centers. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ketamine Wellness Centers or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
A Closer Look at Spravato (Esketamine): How will it be administered? As the P.R. machine kicks into gear to support the launch of Spravato/Esketamine, the first FDA approved Ketamine-derived treatment, Kevin Nicholson (President, CEO of Ketamine Wellness Centers) digs into the details that tend to receive less attention. This episode focuses on how Spravato is administered: Is intranasal delivery effective? What type of clinical environments can provide Spravato to patients? What duration of time will patients have to commit to treatment? www.ketaminewellnesscenters.com/category/podcast/
  continue reading

15 episodes

Artwork
iconShare
 
Manage episode 229049010 series 1756689
Content provided by Ketamine Wellness Centers. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ketamine Wellness Centers or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
A Closer Look at Spravato (Esketamine): How will it be administered? As the P.R. machine kicks into gear to support the launch of Spravato/Esketamine, the first FDA approved Ketamine-derived treatment, Kevin Nicholson (President, CEO of Ketamine Wellness Centers) digs into the details that tend to receive less attention. This episode focuses on how Spravato is administered: Is intranasal delivery effective? What type of clinical environments can provide Spravato to patients? What duration of time will patients have to commit to treatment? www.ketaminewellnesscenters.com/category/podcast/
  continue reading

15 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide